Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Find starter accounts offering high interest and learn how to compare introductory yields and account features quickly.
25,613 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A Google-backed pilot is testing a portal-like model that surfaces MLS-listed homes via search, changing how buyers a...
House appropriators moved a fiscal 2027 THUD bill that preserves key housing programs but hints at reductions elsewhe...
In a volatile rate environment, energy stocks secretly better than Treasuries are drawing income-focused investors to...
Truist’s head of originations is pushing a curiosity-driven, AI-enabled approach to mortgage lending as rates and dem...
Gulf nations are pouring billions into overseas renewables as oil flows face disruption from tensions with Iran, shif...
Boxabl rolls out Phase 2, using three standardized modules to assemble multiple housing types, expanding beyond the C...
MicroStrategy sold 32 Bitcoin for about $2.5 million, the company’s first crypto cash-out since 2022. With Bitcoin ar...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...
Bitcoin hits $64,000 as a viral altcoin skyrockets daily sends shockwaves through the market. Traders weigh liquidity...
The Amplify Seymour Cannabis ETF (CNBS) is up 105% over the past year, driven by investor bets on federal cannabis re...
SanDisk has surged about 500% in 2026 on AI-driven NAND demand. Yet the stock faces a deeply concerning risk: depende...